Member Info for Tyke68

Is semantic part of the company? If so can he be classed as an insider? If so, all his posting of AI quotes stating the values of phase 2 compared to phased 1 can that with hindsight be classed as misleading investors?

All the RNSs over the last 2 years saying going to be meeting the FDA etc which have never actually occurred. Is that classed as misleading investors?

TB and family selling his shares at 1.1p compared against the current sp of 0.57p which has never been explained. The statements saying we all shareholders, is that factually wrong if TB doesn’t hold any shares in IBAI directly?

MCW are doing very well out of all this but what about IB/IBAI shareholders?

No ambiguity, just answers seems to have been written the wrong way round. No answers, just ambiguity!

It will be interesting to see if Apex actually reply.

Let’s see what next week brings and if we get any answers. Maybe TB will quote the downfall of Sinclair rather than comparing us to Apple?

Fingers crossed we get a pleasant surprise.

Thanks

Thanks Xviolet

It is nice to know Mike replies to some people.

A couple of points you raised:

MCW own the rights to the Gabriel trial data even though they seem to be based on our trial data experience by the MCW staff. That seems like we have wasted our time if they can (what’s stopping them) then apply for subsequent RPDD vouchers. That’s $200m possibly wasted.

Also the “referencing” bit you imply other studies can’t reference “that does not mean that additonal academic studies can reference the existing Phase 1.” but then say maybe MCW is just referencing. Did you mean they can reference our data?

Unfortunately we seem to have wasted years on GAM but we are going to let others gain the financial rewards. A lot of people invested based on the GAM trial so the company should try to gain some financial rewards somehow.

Let’s see what the annual report says. Thanks for letting us know the details.

Thanks

Xviolet

If we want to retain staff then we need to think about hitting these sp’s (and well above to make them worthwhile)

“The following Options were granted to key non-Board IB staff and service providers:

Options Granted

Exercise Price

Vesting Schedule from the date of grant (February 2025)

1,000,000

£0.0145

50% after 1 year and the balance after 2 years

550,000

£0.0145

50% after 1 year; 25 % vests after 2 years; the balance vests after 3 years

Up to 6,000,000

£0.04

1 000 000 vests after 1 year; each remaining tranche of 1 000 000 vests upon a qualifying sale of IB Nimble, but not before the first anniversary of the grant

All Options held by IB staff are subject to continued employment at the time of vesting.”

The 6000000 shares person would only make £120k if the sp hits 6p. Have they got a buyer lined up for Nimble? The 1 year anniversary is up already.

I think if we got above 4p we might all be more positive.

Maybe we will find out more next week with the annual results, assuming they aren’t delayed.

Thanks, have a good rest of the weekend

Xviolet did the company reply to your questions?

Thanks

No reply from Apex Group, so I have managed to track down

Joshua Farrow

Country Head of Operations

joshua.farrow@apexgroup.com

+ 44 (0) 204 549 0727

I have emailed him, let’s see if we get a reply about asking questions at the AGM etc

Thanks

Sorry Max

Or maybe 16:30 Wisconsin time?

Apologies

My last post seems to have been posted with the “end” before the “middle”. My old age/poor IT skills letting me down again.

However, it allows me add a further comment.

For two years we have been promised the GAM trial results but we are still waiting, even though they were submitted over 10 weeks ago. We seems to have gambled the company on the clinical trial without realising that we were not in the control of its speed and destiny. The MCW people were the ones who were in charge and decided what to submit and when. Their taking the time to extend, delay etc has left the company in this situation.

Sell the data to a far bigger company who can use it to make it succeed (or fail) far quicker. I still believe GAM could be the magical cancer elixir and help many patients, we/I sometimes forget that because of our financial losses but personal losses are far worse.

The tax write offs, possible vouchers etc make it valuable but only if we commit to sell. But that can’t happen until the data is published. So CC/JC not MS/KS or TB I would say hold the future of the company in their hands and they don’t hold any financial incentives to see IB/IBAI to do well.

Thanks/sorry

No annual results this week then. They could be editing TB’s statement to take out all the usual excuses. People still have the chance to guess what they will say.

What we need from them now is “not ambiguity, just answers”. If they promote that they should actually have the manners to do that for shareholders. How can customers trust their advertising when they don’t actually follow that mantra themselves.

We deserve to be treated with manners and told the truth.

Plus TB needs to get Apex to actually respond to shareholders or change the company secretary, still no response.

Friday rant (possibly) over.

Have a good weekend everybody

Thanks

T

Or maybe we have just received an offer for the company and they are thinking about it. So long as it’s not Truetide!

Posters have mentioned previous share prices this has achieved. So maybe the board could explain what actions to get it back to those levels they are going to do. What’s the opposite of shenanigans? The sp has fallen under their watch, yes we have had dilution to fund projects but ultimately those projects should increase the mcap not destroy it

BB

Not even the board could blame the Middle East war, which only started this year. However, it could be used to promote IB Zero as no critical/rare minerals are needed so no possible supply chain issues.

Still no response from Apex, it is like they are deliberately avoiding us.

Thanks

A challenge for today, building on what BB has just said what “excuses” do you think will appear in the annual report, maximum of 2 per person.

I will start us off with an easy one

“We are shareholders as well”

A bit of fun to lighten the mood

Good luck, thanks

Cautious

I have just sent a message to Apex,the company secretary, asking how to raise questions and pointed out they did not actually reply in January when asked how we could organise a meeting to discuss our issues. If they don’t reply again then maybe TB can explain why they don’t respond to shareholders and maybe we should change our company secretary.

Thanks

Cautious

Thank you

Let’s see what the annual report statement says. Then if need be we could table questions at the AGM maybe? Don’t know if anybody on here has experience of doing that and could advise us.

Let’s see what happens

Thanks

So looking back at last few annual reports, you can see a trend of the board acknowledging the mcap is lower than expected. So my question is when are they finally going to show the shareholders an actual plan to rectify this problem?

If they can’t fix the problem, in fact the Mcap has actually fallen, repeatedly, when will we get people who can. World leading tech at Poundland prices!

No ambiguity just answers please

Thanks

“2023 annual report

With an unprecedented and increasing number of trials currently underway, our focus in 2023 is to convert as many as possible of those trial sites to long-term customers.

It is five years since IQ-AI acquired Imaging Biometrics. Throughout that time the IB team have worked continuously and intensively to innovate and develop what has now become a valuable portfolio of medical IP. We believe that the cumulative accretion of value during this time is not adequately reflected in the current market valuation of the Company, and we are now considering how best to address this anomaly.

2024 annual report

The new financial year has started off well, and revenue to date is higher than the comparable period in 2023. If this trend continues, we expect to exceed last year's revenue.

2025 annual report

•We are expecting a modest loss this year, and expect to at least break even, or achieve a profit next year, if current trends continue.

· GE Healthcare is now a sales partner, with training for their sales and marketing teams recently completed. GEH has provided the Company with promising sales projections.

•Although there has been considerable product development and innovation over past years, profits have been elusive. Currently our market capitalisation is around £1.8m, one of the lowest it has been, despite obvious value enhancement. The Company currently has no debt, a large bank of IP, and the potential of revenue and further value realisation from the Clinical trial and EAP initiatives and developed products. The directors share the frustration of shareholders with the valuation accorded the Company by the market, not least because we are also significant shareholders. The Company continues to have huge potential in the opinion of the directors, though this does not appear to be a view shared by the market if one takes the current share price as a guide.”

Just a reminder of what the February RNS said before we get the annual report:

“Though substantial technical and developmental progress has been made over these years, it has not resulted in a concomitant commercial and revenue reward for shareholders.

With the current market capitalisation of approximately £1.2m, our focus will be on how to address and correct the wide gap between market perception and our actual and anticipated operational performance.

Trevor Brown CEO of IBAI commented. "We recognise and share the frustration and disappointment experienced by shareholders in recent years and are determined to find a new modus operandi for the future. In the current year we are projecting a small profit and importantly, expect to have sufficient working capital without the need to approach shareholders for new funds before this year end and hopefully beyond."

So will we be given some more relevant information. Even the last sentence can be read two ways. Did they mean the year 2025 we will make a profit or the year 2026?

Could they possibly share their plan/modus operandi so we can judge them against it?

To use their own phrase (thanks Max) “no ambiguity just answers” that is what we as shareholders want!

Maybe that could be the name of the group if we ask questions at the AGM.

Max

Yes, Good news equals a sp normally

Thanks

Well that’s not good a start to the day. Do they know something or are they just guessing what the annual results will be?

Thanks

Mornington Oz

We are all just waiting for the end of year results and the GaM trial data being published. We will then either celebrate or cry.

Hopefully at some point it starts fulfilling its potential. However, for that to happen the company needs to admit to previous mistakes and how to correct them going forward.

Or just sell to the highest bidder.

Thanks

Cheers Max

I would say very ironic. We have people who can create world leading tech, it is just a pity they don’t seem to have people who understand why they struggle with sales.

Thanks

Thanks Max

It doesn’t say where they will be doing this training. Will it be on twitter, YouTube, webinar etc? No links to sign up etc. Yet again the communication is terrible. Can they not learn to explain things clearly and engage with prospective customers etc?

I wonder if they have done an email campaign to prospective users. The 40ish institutions mentioned a few years ago would be a good start. We seem to just use twitter. Pay for an advert as we have discussed previously. They need to create some traction and get people told and then buying our products.

If they can’t do it then sell the technology to a bigger company that can.

Let’s see what revenue last year was or if they have seen a significant increase since Mike has focussed fully on this not GaM.

Thanks (sort of rant over)

Malletp

It might be worth telling the company this as their website https://imagingbiometrics.com/cpt-codes/ just talk about the ready to go codes. Are we missing an opportunity, who knows?

Thanks